To explore , using MRI , the disease-modifying effect of strontium ranelate ( SrRan ) treatment on cartilage volume loss ( CVL ) and bone marrow lesions ( BMLs ) in a subset of patients from a Phase III clinical trial in knee osteoarthritis ( OA ) ( SrRan Efficacy in Knee OsteoarthrItis triAl ( SEKOIA ) ) .